People
Postdocs

Adam Pines
Postdoctoral Research Fellow
Adam Pines is a postdoctoral scholar investigating how the brain adapts and changes over time. His background is in neurocognitive development, including cognitive function in mood disorders in youth, hierarchical brain development, and hierarchical cortical processing broadly. His degree is in neuroscience.
In the BSL, Adam will be applying his skillsets in functional neuroimaging and data science to evaluate how TMS changes the brain over time alongside individual variability in these sequences. Ultimately his goal is to connect these pathways to remission with trajectories of mood disorder emergence.

Kenneth Shinozuka
Postdoctoral Research Fellow
Kenneth Shinozuka, PhD, is a postdoctoral fellow conducting research on the neuroscience of psychedelics. He is interested in psychedelics as tools for treating a wide range of psychiatric conditions and for advancing the study of consciousness. At the BSL, Kenneth will be leading a study administering the psychedelic ibogaine to Ukrainians with PTSD, as well as a study using a novel ultrasound technology to target ketamine more locally in the brains of patients with chronic pain. Prior to doing his postdoc, Kenneth received his BA in neuroscience from Harvard University and his PhD in psychiatry from the University of Oxford, where he also specialized in psychedelic research.

Masataka Wada
Postdoctoral Research Fellow
Dr. Wada is a postdoctoral scholar in the Department of Psychiatry & Behavioral Sciences at the Stanford University School of Medicine. He is a board-certified psychiatrist and holds a PhD in neuroscience.
His clinical and research interests center on psychiatric disorders in treatment-resistant conditions. To address these challenges, Dr. Wada is engaged in exploring electrophysiological, neuroimaging, and neuromodulation techniques, including repetitive Transcranial Magnetic Stimulation (rTMS) and Deep Brain Stimulation (DBS). He spearheaded a significant Randomized Controlled Trial (RCT) that involved 180 patients with treatment-resistant depression, aiming to develop an innovative rTMS-based treatment. His efforts have led to him receiving awards at international conferences on three occasions for his significant contributions.
Dr. Wada’s scholarly work includes publications on the electrophysiological characteristics of psychiatric disorders and the effects of neuromodulation on clinical symptoms and neuroimaging features. Additionally, he has been the recipient of two scholarships and three grants, further highlighting his contributions to the field.








